Harvard Pilgrim Update: Judge Denies Preliminary Injunction Filed by New England Pharmacies
The preliminary injunction filed by three pharmacies in New England against Harvard Pilgrim, alleging that a change in their reimbursement/coverage of compounded medications was damaging to beneficiaries, has been denied by the judge.
Click here for a copy of the decision, provided by IACP's counsel.
Click here for a Boston Globe editorial, "More Nuanced Rules Needed at Harvard Pilgrim," August 6, 2013.
IACP Members: Please note that IACP prepared an amicus brief for this case which was excluded by the judge. We are holding it for now as this case may continue to proceed and, unfortunately, we may need it for other cases against third-party plans seeking to reduce or eliminate coverage of compounded medications.
Unhappy Patients Voice Displeasure on Harvard Pilgrim's Facebook Page
While the Harvard Pilgrim situation continues to swirl, the company's Facebook page is the target of many unhappy customers who are not pleased that their compounded meds will no longer be covered. Click here to visit Harvard Pilgrim's Facebook site. The company states: Many of you have questions and comments about our recent decision to discontinue coverage of compound medications. Our goal is to provide our members and providers with access to a wide variety of safe and effective medications. If you and your physician feel a compound medication is medically necessary, your physician may submit to our review process on your behalf. Harvard Pilgrim will review your request within one business day. We encourage you to contact our Member Services team with any questions via our secure message portal here http://bit.ly/1cbqlTf or by calling 1-888-333-4742.
For those IACP members with patients being affected by this situation, be sure to send them to Harvard Pilgrim's message portals noted above to voice their opinions. IACP will continue to keep you apprised of this situation. Please email firstname.lastname@example.org with any questions.